Delivery Order 36F79718D0403-15B50526F00000182

Federal Medical Center Carswell issued a $22,725.09 delivery order to Daiichi Sankyo, Inc. on June 1, 2026, for TURALIO 125mg (pexidartinib), 120-count oral capsules, with ultimate completion by June 30, 2026. The order was placed under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB). Place of performance is Basking Ridge, New Jersey. Daiichi Sankyo supplies this specialized medication—indicated for treatment of tenosynovial giant cell tumor—to VA healthcare facilities within Veterans...

Federal Medical Center Carswell issued a $22,725.09 delivery order to Daiichi Sankyo, Inc. on April 1, 2026, for TURALIO 125mg (120-count bottles) under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB). The order is placed against a single-award blanket purchase agreement established with the VA National Acquisition Center on May 22, 2025, and effective through May 21, 2026, with four optional one-year renewal periods. The BPA ceiling is $80,206.95 and covers TURALIO in 125mg and 200mg...

This delivery order awards $22.73M to Daiichi Sankyo, Inc. for the supply of TURALIO (pexidartinib) 125mg capsules in 120-count bottles, with an ultimate completion date of January 31, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, issued under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB) and funded by Federal Medical Center Carswell, a civilian facility within the Department of Veterans Affairs. Daiichi Sankyo will perform the...

Daiichi Sankyo, Inc. received a delivery order award from the Federal Medical Center Carswell valued at $22,061.05 for the supply of TURALIO 125mg capsules (120-count) with a completion date of December 31, 2025. The contract is structured as a firm fixed-price delivery order under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB) and was issued without a set-aside designation. The products will be delivered to Basking Ridge, New Jersey. Daiichi Sankyo specializes in pharmaceutical...

Daiichi Sankyo, Inc. was awarded a delivery order valued at $48,124.16 by Veterans Integrated Service Network 20 (VISN 20), part of the Department of Veterans Affairs, on January 20, 2025. The contract, which carries a firm fixed-price structure with no set-aside designation, covers the supply of TURALIO (pexidartinib) pharmaceutical products for delivery to a location in Cary, North Carolina, with a completion deadline of September 30, 2025. This delivery order falls under the GSA...

This is a federal contract award to Daiichi Sankyo, Inc., a pharmaceutical manufacturer, for the supply of TURALIO 125mg capsules. The contract, valued at $208,538.07, is a delivery order contract with a firm fixed price and was awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 20. The contract has an ultimate completion date of September 30, 2026. Daiichi Sankyo, Inc. is the prime contractor, and the contract is not a set-aside. The company...

Takeda Pharmaceuticals America Inc. received a $319,551.93 firm fixed-price delivery order from the Federal Correctional Institution Fort Worth on October 1, 2025, with performance completion targeted for September 30, 2026. This delivery order, issued under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB), represents a child contract leveraging pre-negotiated terms and pricing established through Takeda's broader federal contracting vehicles. The award carries no set-aside designation,...

The Federal Correctional Complex Florence, a civilian agency of the Bureau of Prisons, awarded a delivery order to Takeda Pharmaceuticals America, Inc. for foundation care pharmaceutical chemotherapy on April 1, 2026. This firm fixed-price delivery order, valued at $14,385.75 with an ultimate completion date of April 30, 2026, carries no small business set-aside designation and represents performance in Orlando, Florida. The award is a child contract under the parent General Services...

<p>Federal Medical Center Carswell issued a delivery order to Exelan Pharmaceuticals Inc. on May 1, 2026, for $6,783.45 to supply Lenalidomide 20 mg capsules, with a ceiling value of $6,783.45 under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).</p> <p>Place of performance is Boca Raton, FL. The order is firm fixed price with an ultimate completion date of May 31, 2026. No set-aside applies.</p>

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 3, 2026, with a ceiling value of $11,734.84 for Talzenna 0.5 mg softgel capsules (30-count units). The order is firm fixed price with an ultimate completion date of March 24, 2026. Place of performance is Conshohocken, PA. The delivery order was issued without a set-aside.</p>